Özge has a MSc. in Molecular Genetics from the University of Leicester and a PhD in Developmental Biology from Queen Mary University of London. She worked as a Post-doctoral Research Associate at the University of Leicester for six years in the field of Behavioural Neurology before moving into science communication. She worked as the Research Communication Officer at a London based charity for almost two years.
Articles by Özge Özkaya
Recent Posts
- Fabry gene therapy improves heart health after 1 to 2 years
- Digital app for patient monitoring found helpful in small study
- Phase 2 trial results of oral AL01211 in Fabry patients likely this year
- Same mutation, different outcomes: My family’s Fabry story, part 2
- Woman with Fabry has 2 disorders affecting her heart, kidneys
- How I work to prevent infection in life post-transplant
- 1 more study may be enough for Fabry gene therapy approval: FDA
- ST-920 gene therapy lowers Fabry disease severity in trial
- Screening for Fabry ‘important’ in chronic kidney diseases: Study
- Same mutation, different outcomes: My family’s Fabry story, part 1